Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
50.44 USD | +5.24% | +6.29% | -15.60% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.60% | 5.78B | |
-4.66% | 87.53B | |
+1.32% | 40.42B | |
-18.92% | 29.48B | |
+57.86% | 25.43B | |
-17.74% | 11.49B | |
-43.00% | 11.3B | |
-9.14% | 11.1B | |
+5.24% | 8.75B | |
-8.42% | 7.99B |
- Stock Market
- Equities
- APLS Stock
- News Apellis Pharmaceuticals, Inc.
- Apellis Pharmaceuticals : Wedbush Adjusts Price Target for Apellis Pharmaceuticals to $31 From $39, Maintains Neutral Rating